Faiz Hussain
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Faiz Hussain has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Bhushan Nagar
Department of Biochemistry, McGill University, Montreal, Quebec, Canada
2 shared publications - Heidi Gytz
McGill University
2 shared publications - Uri David Akavia
McGill University
2 shared publications Abdullah Malik
Department of Internal Medicine; University of Illinois College of Medicine at Peoria, USA
1 shared publication- Christopher Jf Cameron
Yale University
1 shared publication - Denis Paquette
Department of Biochemistry and Rosalind & Morris Goodman Cancer Research Center, McGill University, Montréal, Québec, H3G 1Y6, Canada
1 shared publication
Latest Publications
- Open Access
- 16 August 2022
- Published by Wolters Kluwer Health in HemaSphere
- Vol. 6 (Suppl) , 26-27
P-020: IMPLICATIONS OF SOCIOECONOMIC DISTRESS ON NUTRITIONAL STATUS AND KIDNEY FUNCTION IN PEOPLE WITH SICKLE CELL ANEMIA
- 16 August 2022
- Published by Wolters Kluwer Health in HemaSphere
- Vol. 6 (Suppl) , 26-27
Open AccessP-020: IMPLICATIONS OF SOCIOECONOMIC DISTRESS ON NUTRITIONAL STATUS AND KIDNEY FUNCTION IN PEOPLE WITH SICKLE CELL ANEMIA
- Open Access
Receptor Mediated Delivery of Cas9-Nanobody Induces Cisplatin Synthetic Dose Sensitivity
The CRISPR/Cas9 system has shown great potential for precisely editing genomic DNA sequences by introducing site-specific DNA cuts that are subsequently repaired by the cell. However, delivery of the CRISPR ribonucleoprotein remains an understudied area and hinders realizing the full potential of the system. We prepared Cas9 ribonucleoprotein complexes chemically conjugated to the 7D12 nanobody and demonstrate receptor-mediated transfection of Cas9 into A549 non-small-cell lung cancer cells via binding to the epithelial growth factor receptor for subsequent cell internalization. We further show that transfection with a Cas9 ribonucleoprotein targeting the BRCA2 gene results in an enhanced sensitivity to the chemotherapeutic drug Cisplatin, and thereby induces a synthetic dose lethality in A549 cells.
Open AccessReceptor Mediated Delivery of Cas9-Nanobody Induces Cisplatin Synthetic Dose Sensitivity
The CRISPR/Cas9 system has shown great potential for precisely editing genomic DNA sequences by introducing site-specific DNA cuts that are subsequently repaired by the cell. However, delivery of the CRISPR ribonucleoprotein remains an understudied area and hinders realizing the full potential of the system. We prepared Cas9 ribonucleoprotein complexes chemically conjugated to the 7D12 nanobody and demonstrate receptor-mediated transfection of Cas9 into A549 non-small-cell lung cancer cells via binding to the epithelial growth factor receptor for subsequent cell internalization. We further show that transfection with a Cas9 ribonucleoprotein targeting the BRCA2 gene results in an enhanced sensitivity to the chemotherapeutic drug Cisplatin, and thereby induces a synthetic dose lethality in A549 cells.
- Open Access
Homology Directed Repair by Cas9:Donor Co-localization in Mammalian Cells
Homology directed repair (HDR) induced by site specific DNA double strand breaks (DSB) with CRISPR/Cas9 is a precision gene editing approach that occurs at low frequency in comparison to indel forming non homologous end joining (NHEJ). In order to obtain high HDR percentages in mammalian cells, we engineered Cas9 protein fused to a high-affinity monoavidin domain to deliver biotinylated donor DNA to a DSB site. In addition, we used the cationic polymer, polyethylenimine, to deliver Cas9 RNP-donor DNA complex into the cell. Combining these strategies improved HDR percentages of up to 90% in three tested loci (CXCR4, EMX1, and TLR) in standard HEK293 cells. Our approach offers a cost effective, simple and broadly applicable gene editing method, thereby expanding the CRISPR/Cas9 genome editing toolbox. Summary: Precision gene editing occurs at a low percentage in mammalian cells using Cas9. Colocalization of donor with Cas9MAV and PEI delivery raises HDR occurrence.
Open AccessHomology Directed Repair by Cas9:Donor Co-localization in Mammalian Cells
Homology directed repair (HDR) induced by site specific DNA double strand breaks (DSB) with CRISPR/Cas9 is a precision gene editing approach that occurs at low frequency in comparison to indel forming non homologous end joining (NHEJ). In order to obtain high HDR percentages in mammalian cells, we engineered Cas9 protein fused to a high-affinity monoavidin domain to deliver biotinylated donor DNA to a DSB site. In addition, we used the cationic polymer, polyethylenimine, to deliver Cas9 RNP-donor DNA complex into the cell. Combining these strategies improved HDR percentages of up to 90% in three tested loci (CXCR4, EMX1, and TLR) in standard HEK293 cells. Our approach offers a cost effective, simple and broadly applicable gene editing method, thereby expanding the CRISPR/Cas9 genome editing toolbox. Summary: Precision gene editing occurs at a low percentage in mammalian cells using Cas9. Colocalization of donor with Cas9MAV and PEI delivery raises HDR occurrence.
- Open Access
- 1 January 2018
- Published by Elsevier in Respiratory Medicine Case Reports
- Vol. 25, 233-234
A devastating cardiovascular event in an adult cystic fibrosis patient: An unforeseen outcome of increasing life expectancy
- 1 January 2018
- Published by Elsevier in Respiratory Medicine Case Reports
- Vol. 25, 233-234
Open AccessA devastating cardiovascular event in an adult cystic fibrosis patient: An unforeseen outcome of increasing life expectancy